NeuBase Therapeutics (NBSE) Peer Comparison
$0.38
$0.00 (0.00%)As on 24-May-2024 09:30EDT
Market cap
$1 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.2
Div. Yield
0 %
Edit
| NeuBase Therapeutics (NBSE) | AVROBIO (AVRO) | Artelo Biosciences Inc. Warrant (ARTLW) | |
|---|---|---|---|
Market cap ($ Mln) |
1 | 5 | 0 |
Revenue ($ Mln) |
-- | 4 | -- |
Net Profit ($ Mln) |
-14.31 | 30.31 | -- |
Net Margin (%) |
-- | 842.30 | -- |
RoE (%) |
-121.38 | 31.62 | -- |
Price to Earnings |
-- | 0.17 | -- |
Price-To-Book |
0.18 | 0.60 | -- |
Income Statement ($ Mln)
| NeuBase Therapeutics (NBSE) | AVROBIO (AVRO) | Artelo Biosciences Inc. Warrant (ARTLW) | |
|---|---|---|---|
|
Operating Revenue
|
0.00 | 0.00 | 0.00 |
|
Cost of Revenue
|
0.85 | 4.17 | -- |
|
Gross Profit
|
-1.26 | -4.17 | -- |
|
Operating Expenses
|
14.61 | 105.43 | 10.29 |
|
Operating Profit (EBIT)
|
-15.27 | -105.43 | -10.29 |
|
Other Income
|
0.00 | -0.46 | -- |
|
Profit before Tax
|
-13.73 | -105.89 | -10.08 |
|
Provision for Tax
|
-0.97 | 0.16 | -0.21 |
|
Profit after Tax (Net Income)
|
-14.31 | -106.05 | -9.87 |
|
Minority Interest
|
0.00 | -- | -- |
|
Consolidated Profit
|
-8.46 | -105.89 | -- |
Liabilities ($ Mln)
| NeuBase Therapeutics (NBSE) | AVROBIO (AVRO) | Artelo Biosciences Inc. Warrant (ARTLW) | |
|---|---|---|---|
|
Shareholder's Funds
|
9.14 | 75.37 | 19.40 |
|
Minority Interest
|
0.00 | -- | -- |
|
Non-Current Liabilities
|
4.83 | 16.46 | 0.02 |
|
Current Liabilities
|
4.65 | 12.12 | 1.00 |
|
Total Liabilities
|
32.69 | 103.95 | 20.42 |
Assets ($ Mln)
| NeuBase Therapeutics (NBSE) | AVROBIO (AVRO) | Artelo Biosciences Inc. Warrant (ARTLW) | |
|---|---|---|---|
|
Non-Current Assets
|
5.27 | 4.27 | 2.10 |
|
Current Assets
|
13.35 | 99.68 | 18.32 |
|
Total Assets
|
32.69 | 103.95 | 20.42 |
|
Total Debt*
|
5.34 | 17.46 | 0.06 |
|
Net Current Assets
|
8.70 | 86.84 | 17.32 |
Cashflow ($ Mln)
| NeuBase Therapeutics (NBSE) | AVROBIO (AVRO) | Artelo Biosciences Inc. Warrant (ARTLW) | |
|---|---|---|---|
|
Cash From Operating Activities
|
-29.01 | -97.21 | -8.01 |
|
Cash Flow from Investing Activities
|
-0.47 | -0.27 | -- |
|
Cash from Financing Activities
|
-0.26 | 0.26 | 0.00 |
|
Net Cash Inflow / Outflow
|
-- | -97.21 | -- |
Ratios
Profitability Ratios
| NeuBase Therapeutics (NBSE) | AVROBIO (AVRO) | Artelo Biosciences Inc. Warrant (ARTLW) | |
|---|---|---|---|
|
ROCE (%)
|
-76.25 | -76.50 | -50.81 |
|
ROE (%)
|
-121.38 | -86.62 | -50.89 |
|
ROA (%)
|
-47.61 | -68.91 | -48.35 |
|
EBIT Margin (%)
|
-- | -- | -- |
|
Net Margin (%)
|
-- | 23,255.92 | -- |
|
Cash Profit Margin (%)
|
-- | -- | -- |
Growth Ratios
| NeuBase Therapeutics (NBSE) | AVROBIO (AVRO) | Artelo Biosciences Inc. Warrant (ARTLW) | |
|---|---|---|---|
|
Revenue Growth (%)
|
-- | -- | -- |
|
EBIT Growth (%)
|
50.47 | -- | -- |
|
Net Profit Growth (%)
|
57.67 | 9.92 | -32.77 |
|
EPS Growth (%)
|
59.46 | -- | -- |
|
Book Value Growth (%)
|
-73.74 | -- | -- |
Valuation Ratios
| NeuBase Therapeutics (NBSE) | AVROBIO (AVRO) | Artelo Biosciences Inc. Warrant (ARTLW) | |
|---|---|---|---|
|
Price / Earnings
|
-0.02 | -- | -- |
|
Price / Book Value
|
0.03 | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- |
|
EV/EBITDA
|
0.50 | 0.72 | 1.70 |
|
Market Cap ($ Cr)
|
-- | -- | -- |
Solvency Ratios
| NeuBase Therapeutics (NBSE) | AVROBIO (AVRO) | Artelo Biosciences Inc. Warrant (ARTLW) | |
|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.23 | 0.00 |
|
Short term debt to equity ratio
|
0.05 | 0.01 | 0.00 |
|
Current Ratio
|
2.87 | 8.23 | 18.36 |
|
Quick Ratio
|
2.87 | 8.25 | -- |
|
Interest Coverage
|
-2,704.96 | -352.62 | -2,057.40 |
Operating Efficiency Ratios
| NeuBase Therapeutics (NBSE) | AVROBIO (AVRO) | Artelo Biosciences Inc. Warrant (ARTLW) | |
|---|---|---|---|
|
Debtors to sales (%)
|
-- | -- | -- |
|
Asset Turnover
|
0.00 | 0.00 | 0.00 |
|
Receivable days
|
-- | -- | -- |
|
Inventory Days
|
-36.95 | -130.02 | -- |
|
Payable days
|
528.11 | 169.65 | -- |
|
Cash Conversion Cycle
|
-- | -- | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
